Purchase Price Allocation (IFRS 3 / ASC 805)
Multi-Period Excess Earnings Method (MEEM) for customer contracts and Relief-from-Royalty for technology and trade names, with deferred revenue adjustments and opening balance sheet support.
UK · US · Cross-border financial reporting
Independent Purchase Price Allocation & Impairment Valuations
Institutional-grade intangible asset valuation and goodwill impairment testing compliant with IFRS 3, ASC 805, and IAS 36. Seamless audit tie-out and full footnote disclosures.
Request a Valuation ScopeValuation evidence that connects the deal to your financial statements
For CFOs, controllers and corporate development teams managing acquisition accounting and annual goodwill impairment reviews.
WARA & WACC Reconciliation
A rigorous Weighted Average Return on Assets (WARA) cross-check against the Weighted Average Cost of Capital (WACC), with reconciled assumptions supporting audit sign-off.
Goodwill & Intangible Impairment (IAS 36 / ASC 350)
Cash-Generating Unit (CGU) definition under IAS 36 and reporting unit analysis under ASC 350. Value in Use (VIU) DCF models for IAS 36, sensitivity tables and disclosure draft notes aligned to your reporting framework.
Independent valuation · Clear scope
Request a Valuation Scope
Share your requirements so we can define the valuation scope, information needed and timetable.